{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-059349","form_type":"8-K","ticker":"KPTI","cik":"0001503802","company_name":"Karyopharm Therapeutics Inc.","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.249623+00:00","generated_at":"2026-05-16T01:43:07.124338+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Karyopharm shareholders approve increase in authorized shares to 111M at special meeting","bullets":["Authorized common stock raised from 53,333,333 to 106,000,000; total capital shares from 58,333,333 to 111,000,000.","Vote: 9,436,123 for, 3,213,329 against, 25,465 abstain; adjournment proposal also approved but not needed.","Certificate of amendment filed with Delaware Secretary of State on February 18, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-059349","json":"https://secwatch.observer/filing/0001193125-26-059349.json","markdown":"https://secwatch.observer/filing/0001193125-26-059349.md","text":"https://secwatch.observer/filing/0001193125-26-059349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526059349/0001193125-26-059349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526059349/kpti-20260218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:43:07.124338+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}